CRDF FY 2017 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$505,000+32.5% YoY

Gross Profit

-$1M-258.6% margin

Operating Income

-$26M-5068.5% margin

Net Income

-$25M-4932.1% margin

EPS (Diluted)

$-51.71

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$12M

Total Liabilities

$6M

Stockholders' Equity

$7M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$505,000	$381,000	+32.5%
Gross Profit	-$1M	-$1M	+3.2%
Operating Income	-$26M	-$40M	+36.2%
Net Income	-$25M	-$39M	+36.5%